EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis

Chengyan Yang, Kun Gao, Shuangshuang He, Mengyuan Liu, Ping Ai

Current Oncology · 29.06.2026 · 33 (7) · 390

DOI: 10.3390/curroncol33070390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 29.06.2026. Verfasst von Chengyan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, C…. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck neuroendocrine carcinoma (HN-NEC) is exceedingly rare. Standardized treatment strategies for this malignancy remain unestablished. This study aimed to explore promising treatment modalities, and to identify prognostic factors in HN-NEC. Materials and Methods: Thirty-nine patients diagnosed with HN-NEC at West China Hospital of Sichuan University between 2006 and 2025 were enrolled. The 5-year survival rates were estimated by Kaplan–Meier analysis. The log-rank test and Firth’s penalized Cox multivariable analysis regression model were used to identify prognostic factors.

Results

The 5-year locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), and overall survival (OS) rates for patients who did and did not receive radiotherapy were 63.2% vs. 29.6% (p = 0.031), 75.5% vs. 48.0% (p = 0.065), and 81.4% vs. 46.9% (p = 0.039), respectively. Laryngeal NEC was associated with poorer 5-year DMFS (41.2% vs. 87.5%, p = 0.023) and 5-year OS (38.1% vs. 92.9%, p = 0.027) compared with non-laryngeal HN-NEC. Radiotherapy (HR = 0.152, 95% CI: 0.025–0.757, p = 0.022) was a potentially protective factor influencing LRRFS.

Conclusions

Radiotherapy may be associated with improved LRRFS in patients with HN-NEC. HN-NEC originating in the larynx appeared to be associated with a poorer prognosis compared with other primary sites of the head and neck.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsCarcinoma, NeuroendocrineHumansPrognosisFemaleRetrospective StudiesMaleMiddle AgedAgedAdult

Stichwörter der Autor:innen

head and neck neuroendocrine carcinomalarynxprognosisradiotherapy

Autor:innen und Institutionen

  • Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China.
  • Department of Oncology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.

Zitieren

APA

Yang, C., Gao, K., He, S., Liu, M., & Ai, P. (2026). Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis. Current Oncology, 33(7), 390. https://doi.org/10.3390/curroncol33070390

Vancouver

Yang C, Gao K, He S, Liu M, Ai P. Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis. Current Oncology. 2026;33(7):390. doi:10.3390/curroncol33070390

BibTeX
@article{Yang2026,
  author = {Yang, Chengyan and Gao, Kun and He, Shuangshuang and Liu, Mengyuan and Ai, Ping},
  title = {Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {7},
  pages = {390},
  doi = {10.3390/curroncol33070390}
}
Kostenlos starten →